Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The global inhalation anesthesia market size is calculated at USD 1.64 billion in 2025 and is expected to reach around USD ...

The demand for inhalation and nasal spray generic drugs is growing as these medications provide affordable and effective treatment options for respiratory ailments like asthma, COPD, and allergies.

Aztreonam for inhalation solution is approved by the FDA to improve respiratory symptoms in patients with cystic fibrosis with P. aeruginosa infection 6. Analysing issues in the treatment of ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 ...

According to STAT, the study demonstrated that xenon gas inhalation not only reduced ... in the field of Alzheimer's disease research and treatment is that it is extremely difficult to design ...

Multiple animal models have shown the inhaled treatment approach to be much more effective at treating respiratory infections, making it likely to reduce costs and ease the burden of care on ...